Eligibility for Low-Dose Rivaroxaban Based on the COMPASS Trial: Insights from the Veterans Affairs Healthcare System

Akash Kataruka, Dhruv Mahtta, Julia M. Akeroyd, Ravi S. Hira, Dhruv S. Kazi, John A. Spertus, Deepak L. Bhatt, Laura A. Petersen, Christie M. Ballantyne, Salim S. Virani

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Fingerprint

Dive into the research topics of 'Eligibility for Low-Dose Rivaroxaban Based on the COMPASS Trial: Insights from the Veterans Affairs Healthcare System'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology